← Open Payments lookup

SAMANTHA NICE: Open Payments

NPI 1497424071 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,222 in 76 payments from 18 companies in 2025. Trend: 2023 $1,271 · 2024 $1,096 · 2025 $1,222

Food & beverage: $1,222
CompanyPaymentsAmount
Janssen Biotech, Inc.21$310
Takeda Pharmaceuticals U.S.A., Inc.12$165
ABBVIE INC.7$135
Ipsen Biopharmaceuticals, Inc4$98
Phathom Pharmaceuticals, Inc.10$73
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56
GENZYME CORPORATION2$55
Regeneron Healthcare Solutions, Inc.2$51
Gilead Sciences, Inc.2$46
Madrigal Pharmaceuticals2$45

Products named: TREMFYA, ENTYVIO, DUPIXENT, IQIRVO, VOQUEZNA, XIFAXAN, REZDIFFRA, RINVOQ.

Industry payments across NE — which companies pay providers there.